Drug repurposing tactics in the USA: Known active pharmaceutical ingredients in new indications

被引：0
|
作者：
Dooley, Thomas P. [1 ]
机构：
[1] Trends Pharm Dev, 270 Skyline Dr, Trussville, AL 35173 USA
来源：
PULMONARY PHARMACOLOGY & THERAPEUTICS | 2025年 / 89卷
关键词：
Drug repurposing; FDA regulations; Compounding; Medication; Covid-19; SULFOTRANSFERASE;
D O I：
10.1016/j.pupt.2025.102348
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Managing High-Potency Active Pharmaceutical Ingredients-A Drug Sponsor's Guide
    Wollowitz, Susan
    DRUG DEVELOPMENT RESEARCH, 2010, 71 (07) : 420 - 428
  • [32] Comparison of near-infrared spectroscopic methods for the identification of pharmaceutical excipients and active drug ingredients
    Palmer, K. E.
    Jee, R. D.
    Kraunsoe, J. A. E.
    Bellchambers, M.
    Moffat, A. C.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 : S10 - S11
  • [33] A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations
    Pinheiro, Eloan dos Santos
    Ceva Antunes, Octavio Augusto
    Fortunak, Joseph M. D.
    ANTIVIRAL RESEARCH, 2008, 79 (03) : 143 - 165
  • [34] Cyclodextrin Metal-Organic Frameworks as a Drug Delivery System for Selected Active Pharmaceutical Ingredients
    Krukle-Berzina, Kristine
    Lends, Alons
    Boguszewska-Czubara, Anna
    ACS OMEGA, 2024, 9 (08): : 8874 - 8884
  • [35] Amorphous Protic Ionic Systems as Promising Active Pharmaceutical Ingredients: The Case of the Sumatriptan Succinate Drug
    Wojnarowska, Z.
    Knapik, J.
    Rams-Baron, M.
    Jedrzejowska, A.
    Paczkowska, M.
    Krause, A.
    Cielecka-Piontek, J.
    Jaworska, M.
    Lodowski, P.
    Paluch, M.
    MOLECULAR PHARMACEUTICS, 2016, 13 (03) : 1111 - 1122
  • [36] Complex Drug Delivery Systems: Controlling Transdermal Permeation Rates with Multiple Active Pharmaceutical Ingredients
    Daniel A. Davis
    Patricia P. Martins
    Michael S. Zamloot
    Shawn A. Kucera
    Robert O. Williams
    Hugh D. C. Smyth
    Zachary N. Warnken
    AAPS PharmSciTech, 21
  • [37] Complex Drug Delivery Systems: Controlling Transdermal Permeation Rates with Multiple Active Pharmaceutical Ingredients
    Davis, Daniel A.
    Martins, Patricia P.
    Zamloot, Michael S.
    Kucera, Shawn A.
    Williams, Robert O., III
    Smyth, Hugh D. C.
    Warnken, Zachary N.
    AAPS PHARMSCITECH, 2020, 21 (05)
  • [38] New trends in the biocatalytic production of nucleosidic active pharmaceutical ingredients using 2′-deoxyribosyltransferases
    Del Arco, Jon
    Acosta, Javier
    Fernandez-Lucas, Jesus
    BIOTECHNOLOGY ADVANCES, 2021, 51
  • [39] New options in the processing of highly active pharmaceutical ingredients using high containment systems
    Keil, U
    Andersen, I
    PHARMAZEUTISCHE INDUSTRIE, 2006, 68 (04): : 490 - 494
  • [40] TOXIC DEGRADATION PRODUCTS OF ACTIVE INGREDIENTS - A NEW TARGET FOR QUALITY-CONTROL OF PHARMACEUTICAL PREPARATIONS
    PAAL, TL
    LIPTAKCSEKEY, E
    ACTA PHARMACEUTICA JUGOSLAVICA, 1990, 40 (1-2): : 199 - 206
12345